Ad
related to: cd68 prognosis cancer breast cancer connectioncancer.ucihealth.org has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
3161 15366 Ensembl ENSG00000072571 ENSMUSG00000020330 UniProt O75330 Q00547 RefSeq (mRNA) NM_012485 NM_001142556 NM_001142557 NM_012484 NM_013552 RefSeq (protein) NP_001136028 NP_001136029 NP_036616 NP_036617 NP_038580 Location (UCSC) Chr 5: 163.46 – 163.49 Mb Chr 11: 40.59 – 40.62 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Hyaluronan-mediated motility receptor (HMMR), also ...
[14] [15] [16] Increased SEMA7A expression correlates with poor prognosis in breast cancer patients. [13] Tumors increase SEMA7A expression in an involuting environment, but knockout of SEMA7a in mouse models undergoing involution decreases lymphangiogenesis.
CD68 immunostaining demonstrating macrophages and giant cells in a case of xanthogranulomatous pyelonephritis CD68 ( C luster of D ifferentiation 68) is a protein highly expressed by cells in the monocyte lineage (e.g., monocytic phagocytes , osteoclasts ), by circulating macrophages , and by tissue macrophages (e.g., Kupffer cells , microglia ).
The link between chloroma and acute leukemia was first recognized in 1902 by Dock and Warthin. [16] However, because up to 30% of these tumors can be white, gray, or brown rather than green, the more correct term granulocytic sarcoma was proposed by Rappaport in 1967 [ 17 ] and has since become virtually synonymous with the term chloroma .
The basal-like carcinoma is a recently proposed subtype of breast cancer defined by its gene expression and protein expression profile. [1]Breast cancer can be divided into five molecular subtypes, including luminal subtype A, luminal subtype B, normal breast-like subtype, HER-2 overexpression subtype, and basal-like subtype. [2]
Permanent link; Page information; Cite this page; ... This is a list of major breast cancer cell lines that are primarily used in breast cancer research. [Notes 1 ...
Paraneoplastic cerebellar degeneration (PCD) is a paraneoplastic syndrome associated with a broad variety of tumors including lung cancer, ovarian cancer, breast cancer, Hodgkin’s lymphoma and others. PCD is a rare condition that occurs in less than 1% of cancer patients.
Several types of cancer are associated with high survival rates, including breast, prostate, testicular and colon cancer. Brain and pancreatic cancers have much lower median survival rates which have not improved as dramatically over the last forty years. [4] Indeed, pancreatic cancer has one of the worst survival rates of all cancers.
Ad
related to: cd68 prognosis cancer breast cancer connectioncancer.ucihealth.org has been visited by 10K+ users in the past month